Clincosm LogoSign in Get a demo

acral lentiginous melanoma

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acral Lentiginous Melanoma, CNS Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Houston (Nivolumab)

Active, not recruiting
  • Acral Lentiginous Melanoma
  • +9 more
  • Biospecimen Collection
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2023

Acral Lentiginous Melanoma, Cutaneous Nodular Melanoma, Lentigo Maligna Melanoma Trial in United States (Dinaciclib)

Active, not recruiting
Has Results
  • Acral Lentiginous Melanoma
  • +6 more
  • Mobile, Alabama
  • +190 more
Jan 28, 2023

Acral Lentiginous Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in

Active, not recruiting
  • Acral Lentiginous Melanoma
  • +3 more
  • Biospecimen Collection
  • +4 more
  • Birmingham, Alabama
  • +822 more
Jan 28, 2023

Breast Cancer, Colorectal Cancer, Ovarian Cancer Trial in United States (ATRC-101, Pembrolizumab, Pegylated liposomal

Recruiting
  • Breast Cancer
  • +15 more
  • ATRC-101
  • +2 more
  • Phoenix, Arizona
  • +10 more
Sep 28, 2022

Acral Lentiginous Melanoma Trial in Hong Kong (pembrolizumab)

Active, not recruiting
  • Acral Lentiginous Melanoma
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Prince of Wales Hospital
Feb 15, 2022

Acral Lentiginous Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Cutaneous Melanoma Trial in United States

Recruiting
  • Acral Lentiginous Melanoma
  • +6 more
  • Birmingham, Alabama
  • +309 more
Nov 8, 2021

Acral Lentiginous Melanoma, Mucosal Melanoma Trial in Washington, Tampa, Hackensack (Nivolumab, Ipilimumab)

Unknown status
  • Acral Lentiginous Melanoma
  • Mucosal Melanoma
  • Washington, District of Columbia
  • +3 more
Jan 7, 2020